Experimental study demonstrates that KDM4A inhibition reduces neuroinflammation and enhances functional recovery in ischemic stroke, highlighting a promising target for neuroprotection.
The current results demonstrated KDM4A inhibition improves functional recovery in ischemic stroke by repressing NF-κB activation and subsequent neuroinflammation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: